US Stock MarketDetailed Quotes
SZLSF STAGEZERO LIFE SCIENCES LTD
- 0.015
- +0.014+900.00%
15min DelayClose Jul 12 16:00 ET
1.85MMarket Cap-125P/E (TTM)
0.015High0.002Low2.60KVolume0.002Open0.002Pre Close35.63Turnover0.00%Turnover RatioLossP/E (Static)123.55MShares0.05652wk High-0.18P/B1.85MFloat Cap0.00252wk Low--Dividend TTM123.55MShs Float0.061Historical High--Div YieldTTM900.00%Amplitude0.002Historical Low0.013Avg Price1Lot Size
STAGEZERO LIFE SCIENCES LTD Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 60.59%-3.53M | -655.15K | 97.22%-71.07K | 77.21%-558.28K | -104.82%-2.24M | -192.22%-8.95M |
| Net income from continuing operations | 78.68%-386.35K | -1,722.52%-821.88K | 68.67%-401.54K | -206.84%-1.81M | -52.53%-11.42M | ---9.5M | 97.97%-45.1K | -129.60%-1.28M | 91.91%-590.5K | -9.03%-7.48M |
| Operating gains losses | -92.19%29.41K | 80.57%-188.09K | -2,703.17%-262.55K | 128.57%376.37K | 19.03%-2.24M | --58.44K | 3.64%-967.84K | 99.86%-9.37K | -123.76%-1.32M | -257.79%-2.76M |
| Depreciation and amortization | -69.32%18.28K | -77.52%38.1K | -27.41%59.58K | -36.04%59.58K | -14.10%437.45K | --125.76K | -20.57%169.44K | 54.91%82.08K | -14.50%93.14K | 135.41%509.28K |
| Other non cash items | -82.23%23.58K | 141.53%70.34K | 126.22%176.95K | 118.20%132.7K | -520.52%-1.66M | ---117.37K | -209.00%-169.37K | -784.84%-674.84K | -1,457.55%-729.18K | -227.69%-267.16K |
| Change In working capital | -77.80%210.2K | -27.88%679.17K | -74.98%373.12K | 605.10%946.67K | 905.95%3.71M | --1.14M | 184.09%941.78K | 2,465.65%1.49M | 112.76%134.26K | -471.86%-460.18K |
| -Change in receivables | 81.40%-7.67K | -130.49%-6.24K | -50.35%22.05K | -309.51%-41.21K | 121.57%95.65K | --11.11K | 268.89%20.47K | 147.07%44.42K | -76.65%19.67K | -73.04%43.17K |
| -Change in inventory | --0 | 1,725.61%60.37K | --0 | -80.41%12.68K | 682.05%313.18K | --142.77K | 101.75%3.31K | 200.61%102.4K | 185.64%64.71K | 79.87%-53.81K |
| -Change in prepaid assets | 86.08%30.65K | -12.13%59.9K | -11.14%-118.34K | -21.09%16.47K | 205.87%26.09K | --43.53K | -9.60%68.17K | 25.36%-106.48K | 812.59%20.87K | 54.18%-24.65K |
| -Change in payables and accrued expense | -81.35%167.58K | -52.49%450.43K | -60.81%581.73K | 8,782.63%898.48K | 960.22%3.4M | --957.76K | 229.99%948.08K | 256.25%1.48M | 101.18%10.12K | -173.69%-395.28K |
| -Change in other working capital | -67.41%19.64K | 216.76%114.71K | -234.38%-112.33K | 218.74%60.25K | -326.82%-126.41K | ---13.47K | -157.83%-98.25K | -70.14%-33.59K | 109.22%18.9K | -113.17%-29.62K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 60.59%-3.53M | ---655.15K | 97.22%-71.07K | 77.21%-558.28K | -104.82%-2.24M | -192.22%-8.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 71.01%-20.97K | |||||
| Net PPE purchase and sale | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | -40.69%-101.75K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --80.78K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | 71.01%-20.97K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -70.44%72.09K | -177.34%-87.93K | -47.45%20.86K | -78.40%243.85K | -55.34%1.83M | 650.6K | 215.83%113.7K | -88.68%39.69K | 19.84%1.13M | -57.53%4.1M |
| Net issuance payments of debt | -70.44%72.09K | -202.62%-116.67K | -845.62%-295.95K | 354.85%243.85K | 174.71%290.18K | --332.47K | 215.83%113.7K | 150.62%39.69K | 16.55%-95.68K | -174.84%-388.39K |
| Net common stock issuance | ---- | --18.52K | --279.76K | ---- | -50.36%1.54M | --206K | --0 | --0 | --1.34M | -67.47%3.11M |
| Proceeds from stock option exercised by employees | ---- | --10.22K | --37.04K | ---- | --0 | --0 | --0 | ---- | ---- | 109.68%1.38M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---112.12K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -70.44%72.09K | -177.34%-87.93K | -47.45%20.86K | -78.40%243.85K | -55.34%1.83M | --650.6K | 215.83%113.7K | -88.68%39.69K | 19.84%1.13M | -57.53%4.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 68.22%26.38K | 784.94%64.21K | -94.04%36.3K | -99.09%15.68K | -73.86%1.72M | --33.25K | -100.22%-9.37K | -90.55%609.21K | -73.86%1.72M | 9,175.61%6.6M |
| Current changes in cash | -201.15%-20.85K | -194.11%-40.11K | 105.38%27.91K | 101.85%20.61K | 65.19%-1.7M | ---4.56K | 101.61%42.63K | 76.42%-518.59K | -625.37%-1.12M | -174.66%-4.87M |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---13.01K | ---- | ---- | ---- | ---- | --0 |
| End cash Position | -84.75%5.54K | -27.55%24.09K | -29.15%64.21K | -94.04%36.3K | -99.09%15.68K | --15.68K | -97.91%33.25K | -97.86%90.63K | -90.55%609.21K | -73.86%1.72M |
| Free cash flow | 58.37%-92.94K | 167.28%47.82K | 101.26%7.06K | 90.05%-223.24K | 61.24%-3.53M | ---655.15K | 97.22%-71.07K | 78.47%-558.28K | -104.82%-2.24M | -190.21%-9.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
